Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Institutional Investor > Versant Venture Management, Llc > Profile

Instuitional Investor - Versant Venture Management, Llc

Fund Profile
Filing Period:
Fund Name: Versant Venture Management, Llc
Portfolio Value $388,843,408
Top 13F Holdings
Filing Period:
No. Security Ticker Shares Value % Port
1.
Rayzebio Inc.
 5,158,161 $320,682,869 82.47%
2.
Crispr Therapeutics Ag
 CRSP 498,558 $31,209,731 8.02%
3.
Repare Therapeutics Inc.
 RPTX 2,646,657 $19,320,596 4.96%
4.
Gritstone Bio Inc.
 GRTS 3,561,150 $7,264,746 1.86%
5.
Passage Bio Inc.
 PASG 4,959,769 $5,009,367 1.28%
Insider Monkey Quarterly Strategy
+336.2% Insider Monkey Quarterly Strategy
+144.8% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through November 14th, 2024)